Daniel Geschwind
Neurology · Los Angeles, CANPI 1730102310
Payments from drug & device makers
$1,004,849in general payments, 2019–2025
Across 14 payments — averaging $71,775 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tanabe Pharma America, Inc.$378K
- F. Hoffmann-la Roche AG$310K
- Mitsubishi Tanabe Pharma Holdings America, Inc.$310K
- Biogen$7K
What the payments were for
- Consulting fees$7,22897%
- Food & beverage$1913%
General payments by program year
21
22
23
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tanabe Pharma America, Inc. | 3 | $378,087 |
| F. Hoffmann-la Roche AG | 4 | $310,000 |
| Mitsubishi Tanabe Pharma Holdings America, Inc. | 4 | $309,535 |
| Biogen | 3 | $7,228 |
How this compares
$1,004,849 in reported general payments places this provider in the 95th percentile of 1,996 neurology providers in California.
Other neurology in Los Angeles
- Timothy CloughesyLos Angeles$33.1M
- Perry ShiehLos Angeles$8.2M
- Jeffrey SaverLos Angeles$2.9M
- David PiccioniLos Angeles$2.9M
- David LiebeskindLos Angeles$2.7M
- Michele TagliatiLos Angeles$2.5M
- Jennifer HuiLos Angeles$2.4M
- Susan PerlmanLos Angeles$2.2M
- Jeffrey CummingsLos Angeles$2M
- Bryan SpannLos Angeles$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.